Recursion Pharmaceuticals, Inc. (RXRX) Earnings
NASDAQ·Healthcare·Biotechnology
$3.43
-1.58%
Mkt Cap $1.57B
Next Earnings
In 5 daysMon, May 4, 2026
EPS Estimate
-$0.27
4 analysts
Revenue Estimate
$17.46M
Last quarter: beat by +25.00% on EPS, +44.04% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.57B
P/E
—
Fwd P/E
—
P/S
20.99
Rev TTM
—
EPS TTM
-$1.48